Overview of the Genomics and Targeted Therapy Group

The Genomics and Targeted Therapy Group, in FDA's Office of Clinical Pharmacology, works to advance the application of genomic technologies in the discovery, development, regulation, and use of medications.  

Through pre-market review of therapeutics, policy development, regulatory research, and education, the Group ensures that pharmacogenomic and targeted development strategies are appropriately promoted and proactively applied in all phases of drug development.

Page Last Updated: 12/23/2015
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English